The first pill designed to treat mild to moderate cases of Covid-19 in adults who had at least one risk factor for getting severely sick from the virus was authorized conditionally in the UK.
Veuer’s Johana Restrepo has more.
The first pill designed to treat mild to moderate cases of Covid-19 in adults who had at least one risk factor for getting severely sick from the virus was authorized conditionally in the UK.
Veuer’s Johana Restrepo has more.
The antiviral COVID pill distribution will mirror vaccine rollouts a year ago, given to the highest risk groups first.